↓ Skip to main content

Dove Medical Press

Review of teriflunomide and its potential in the treatment of multiple sclerosis

Overview of attention for article published in Neuropsychiatric Disease and Treatment, May 2009
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (92nd percentile)
  • High Attention Score compared to outputs of the same age and source (80th percentile)

Mentioned by

patent
11 patents
wikipedia
1 Wikipedia page

Citations

dimensions_citation
68 Dimensions

Readers on

mendeley
111 Mendeley
Title
Review of teriflunomide and its potential in the treatment of multiple sclerosis
Published in
Neuropsychiatric Disease and Treatment, May 2009
DOI 10.2147/ndt.s4474
Pubmed ID
Authors

Clemens Warnke, Gerd Meyer zu Hörste, Hans-Peter Hartung, Olaf Stüve, Bernd C Kieseier

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 111 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 <1%
Spain 1 <1%
United States 1 <1%
Unknown 108 97%

Demographic breakdown

Readers by professional status Count As %
Researcher 16 14%
Student > Bachelor 11 10%
Student > Doctoral Student 10 9%
Other 9 8%
Student > Ph. D. Student 9 8%
Other 29 26%
Unknown 27 24%
Readers by discipline Count As %
Medicine and Dentistry 35 32%
Agricultural and Biological Sciences 15 14%
Biochemistry, Genetics and Molecular Biology 5 5%
Neuroscience 5 5%
Pharmacology, Toxicology and Pharmaceutical Science 4 4%
Other 17 15%
Unknown 30 27%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 15. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 23 January 2024.
All research outputs
#2,329,851
of 25,373,627 outputs
Outputs from Neuropsychiatric Disease and Treatment
#294
of 3,132 outputs
Outputs of similar age
#7,112
of 104,032 outputs
Outputs of similar age from Neuropsychiatric Disease and Treatment
#1
of 5 outputs
Altmetric has tracked 25,373,627 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 90th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,132 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.6. This one has done particularly well, scoring higher than 90% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 104,032 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 92% of its contemporaries.
We're also able to compare this research output to 5 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them